MNKD – mannkind corporation (US:NASDAQ)
Stock Stats
News
Reassessing MannKind (MNKD) Valuation After Recent Share Price Reset [Yahoo! Finance]
MannKind Announces U.S. FDA Accepts for Review its Supplemental New Drug Application (sNDA) of FUROSCIX ReadyFlow™ Autoinjector for the Treatment of Edema in Adults with Chronic Heart Failure or Chronic Kidney Disease
MannKind (NASDAQ:MNKD) was given a new $9.00 price target on by analysts at Truist Financial Corporation.
MannKind (NASDAQ:MNKD) is now covered by analysts at Truist Financial Corporation. They set a "buy" rating on the stock.
MannKind (NASDAQ:MNKD) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $7.00 price target on the stock.
Form 4 MANNKIND CORP For: Dec 02 Filed by: Castagna Michael
Form 4 MANNKIND CORP For: Dec 02 Filed by: Thomson David
Form 144 MANNKIND CORP Filed by: Thomson David
Form 144 MANNKIND CORP Filed by: Castagna Michael
Form 4 MANNKIND CORP For: Nov 14 Filed by: Singh Sanjay R
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.